4-Hydroxybenzaldehyde → HCID 178487364, compound
Reaction equation
[CH3:1][O:2][C:3]1[CH:4]=[C:5]([CH:9]([C:12](=O)[CH2:13][C:14]2[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=2)[C:10]#[N:11])[CH:6]=[CH:7][CH:8]=1.[NH2:21][NH2:22].[OH:23][C:24]1[CH:31]=[CH:30][C:27]([CH:28]=O)=[CH:26][CH:25]=1.[F:32][C:33]([F:38])([F:37])[C:34]([OH:36])=[O:35]>C(O)C>[F:32][C:33]([F:38])([F:37])[C:34]([OH:36])=[O:35].[CH3:1][O:2][C:3]1[CH:8]=[CH:7][C:6]2[C:28]([C:27]3[CH:30]=[CH:31][C:24]([OH:23])=[CH:25][CH:26]=3)=[N:11][C:10]3[NH:21][N:22]=[C:12]([CH2:13][C:14]4[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=4)[C:9]=3[C:5]=2[CH:4]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 70 °C
Procedure
2-[3-(methyloxy)phenyl]-3-oxo-4-phenylbutanenitrile (100 mg, 0.38 mmol) was dissolved in ethanol (1 mL), and anhydrous hydrazine (98%, 14 μL, 0.45 mmol) was added. The resulting mixture was heated at reflux for 1 hour. It was cooled, concentrated, and the residue was dried under vacuum for one hour. To this residue was added of 4-hydroxybenzaldehyde (69 mg, 0.57 mmol) and trifluoroacetic acid (1 mL), and the mixture was heated at 70° C. for 18 hours. Then the reaction mixture was concentrated, dissolved in 10 mL of N,N-dimethylformamide and purified by preparatory reverse phase HPLC (Shimadzu LC-8A HPLC, Waters Xterra C18 30 mm×100 mm column, acetonitrile-water-trifluoroacetic eluent). After concentration then lyophillization of the pure fractions 4-[8-(methyloxy)-1-(phenylmethyl)-3H-pyrazolo[3,4-c]isoquinolin-5-yl]phenol trifluoroacetic acid salt (63 mg, 0.13 mmol, 34% yield) was obtained. 1H NMR (400 MHz, d6-DMSO): 7.97-7.94 (d, 1H), 7.50-7.48 (d, 2H), 7.30-7.25 (m, 6H), 7.06-7.02 (m, 1H), 6.95-6.93 (d, 2H), 4.60 (s, 2H), 3.76 (s, 3H); MS (EI) for C24H19N3O2: 382 (MH+).
Workup
- temperatureThe resulting mixture was heated
- temperatureat reflux for 1 hour
- temperatureIt was cooled
- concentrationconcentrated
- customthe residue was dried under vacuum for one hour
- concentrationThen the reaction mixture was concentrated
- dissolutiondissolved in 10 mL of N,N-dimethylformamide
- custompurified by preparatory reverse phase HPLC (Shimadzu LC-8A HPLC, Waters Xterra C18 30 mm×100 mm column, acetonitrile-water-trifluoroacetic eluent)
- concentrationAfter concentration
Sources & evidence
- ORD record
- ord-1f87e1381b6a47e3b0fb1ce774dc46f9
- Source dataset
- uspto-grants-2011_01
- Patent number
- US07872014B2
Reaction notes
Loading…